We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$82.7B
1-Year Est. Return
28.53%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+28.53%
3 Year Est. Return
+81.04%
5 Year Est. Return
+81.98%
10 Year Est. Return
–
AUM
$56.1B
AUM Growth
+$6.71B
(+14%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
4.3%
Top 10 Holdings %
Top 10 Hldgs %
25.67%
Holding
2,792
New
318
Increased
1,272
Reduced
940
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$215M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$201M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$184M |
| 4 |
Bank of America
BAC
|
+$168M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$161M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$97.6M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$73.8M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$62.6M |
| 5 |
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
|
+$60.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.79% |
| 2 | Financials | 8.41% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 5% |
| 5 | Consumer Discretionary | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OKYO
2576
OKYO Pharma
OKYO
$79.8M
| $32.9K | ﹤0.01% |
12,812
| – | – |
|
2577
Fate Therapeutics
FATE
$303M
| $32.9K | ﹤0.01% |
31,007
+1,103
| +4% | +$1.28K |
|
2578
Lisata Therapeutics
LSTA
$10.3M
| $32.3K | ﹤0.01% |
+12,183
| New | +$29.3K |
|
2579
Getty Images
GETY
$131M
| $32.2K | ﹤0.01% |
+19,410
| New | +$34.2K |
|
2580
GoPro
GPRO
$110M
| $32.1K | ﹤0.01% |
42,338
-78,825
| -65% | -$51.2K |
|
2581
Fractyl Health
GUTS
$109M
| $29.9K | ﹤0.01% |
18,486
+4,759
| +35% | +$7.69K |
|
2582
Bit Digital
BTBT
$544M
| $29.7K | ﹤0.01% |
13,582
+1,202
| +10% | +$2.65K |
|
2583
Geron
GERN
$943M
| $29.5K | ﹤0.01% |
20,924
+3,748
| +22% | +$5.31K |
|
2584
Prelude Therapeutics
PRLD
$446M
| $29.5K | ﹤0.01% |
36,393
+1,828
| +5% | +$1.58K |
|
2585
Quantum-Si Incorporated
QSI
$163M
| $29.2K | ﹤0.01% |
+14,881
| New | +$22K |
|
|
CMPS
2586
Compass Pathways
CMPS
$1.85B
| $28.6K | ﹤0.01% |
10,214
-73
| -0.7% | -$275 |
|
2587
Talkspace
TALK
$871M
| $27.9K | ﹤0.01% |
+10,031
| New | +$29.5K |
|
|
AKTX
2588
Akari Therapeutics
AKTX
$13.8M
| $27.7K | ﹤0.01% |
591
| – | – |
|
|
SGMO
2589
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $27.1K | ﹤0.01% |
50,000
-5,000
| -9% | -$2.97K |
|
2590
Precigen
PGEN
$2.19B
| $26.7K | ﹤0.01% |
18,829
-49,486
| -72% | -$70.3K |
|
2591
Offerpad Solutions
OPAD
$21.7M
| $26.3K | ﹤0.01% |
2,891
+202
| +8% | +$2.33K |
|
2592
Black Diamond Therapeutics
BDTX
$117M
| $25.5K | ﹤0.01% |
+10,299
| New | +$19.8K |
|
2593
AdvisorShares Pure US Cannabis ETF
MSOS
$922M
| $25.2K | ﹤0.01% |
10,454
| – | – |
|
2594
Holley
HLLY
$376M
| $24.8K | ﹤0.01% |
+12,408
| New | +$26.3K |
|
|
ORGN
2595
DELISTED
Origin Materials
ORGN
| $21.2K | ﹤0.01% |
1,459
+766
| +111% | +$13K |
|
|
CAPT
2596
DELISTED
Captivision
CAPT
| $20.7K | ﹤0.01% |
18,173
| – | – |
|
2597
Wheels Up
UP
$181M
| $19.2K | ﹤0.01% |
+897
| New | +$22K |
|
2598
Innoviz Technologies
INVZ
$107M
| $18.9K | ﹤0.01% |
11,543
+706
| +7% | +$617 |
|
|
URG
2599
Ur-Energy
URG
$537M
| $17.9K | ﹤0.01% |
+17,033
| New | +$13.6K |
|
2600
Rekor Systems
REKR
$98.4M
| $17.3K | ﹤0.01% |
+14,923
| New | +$15.7K |
|
Similar funds
Cerity Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Cerity Partners held 2,792 positions worth $56.1B, up 14% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Cerity Partners deployed $2.41B of net new capital in Q2 2025, opening 318 new positions and adding to 1,272 existing holdings. Its largest new stake was ExxonMobil: 2,014,446 shares worth $217M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $161M trimmed.
- Cerity Partners's largest Q2 2025 buy was ExxonMobil: 2,014,446 shares worth $217M.
- Cerity Partners added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $201M increase.
- Cerity Partners's biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $161M.
- Cerity Partners fully exited Discover Financial Services in Q2 2025, selling an estimated $33.9M.
- Cerity Partners's ten largest holdings make up 26% of its $56.1B portfolio in Q2 2025.
- Cerity Partners opened 318 new positions and closed 166 in Q2 2025.
- Cerity Partners's portfolio value rose 14% quarter-over-quarter to $56.1B.
Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.